Lansoprazole
Product Images NDC 50090-2225

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-2225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lansoprazole 01)

Chemical structure of lansoprazole, showing its molecular arrangement with characteristic rings and functional groups including a benzimidazole ring system attached to a sulfoxide and a substituted pyridine ring.*

FDA Label Image

Figure 1 (Lansoprazole 02)

A line graph showing the mean severity of day heartburn over days from the start of treatment for evaluable patients. The graph compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with severity rated from 0 (None) to 3 (Severe). The plot shows a decrease in heartburn severity for both Lansoprazole doses compared to placebo over approximately 60 days.*

FDA Label Image

Figure 2 (Lansoprazole 03)

A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients' comparing mean night heartburn scores over approximately 60 days from treatment start. The graph shows three groups: Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with severity scores ranging from 0 (None) to 3 (Severe) on the y-axis and days on the x-axis. Lansoprazole groups show lower mean severity compared to placebo across the timeframe.*

FDA Label Image

Label Image (Lbl500902225)

LANSOPRAZOLE 30 MG capsule label from A-S Medication Solutions with NDC 50090-2225. The label describes the capsules as dark blue and pink, containing 30 mg of lansoprazole USP, and identifies them as enteric-coated pellets in delayed release form. Storage instructions specify 77 degrees Fahrenheit. The package contains 30 delayed release capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.